drugset / Trial / NCT05063604

Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression

NCT05063604

RandomizedParallel-groupOpen-labelTreatment

Summary

To provide evidence on the antidepressant efficacy of two therapeutic treatments: pharmacological treatment (citalopram) and psychotherapy treatment, in women diagnosed with breast cancer and major depression.

Timeline

Start
2022-05-10
Primary completion
2022-05-10
Completion
2022-06-29

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule 20 mg